Chemicalinfo Chemlink Pharm-Chem Net

Chemical Pharmaceutical News

Cediranib Demonstrates Safe, Well Tolerated Antitumour Activity in Patients With Advanced Renal Cell Carcinoma

Cediranib Demonstrates Safe, Well Tolerated Antitumour Activity in Patients With Advanced Renal Cell Carcinoma: Presented at EMUC By Chris Berrie BARCELONA, Spain -- December 1, 2009 -- Cediranib is safe and well tolerated, and shows signif...
分页:[«]1[»]

Powered By Z-Blog 1.7 Laputa Build 70216

Copyright 2005-2009 Your WebSite. Some Rights Reserved.